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542a Tuesday, February 23, 2010supernatant and pellet fractions. Co-sedimentation of NMR-unP with isolated
molluscan thin filaments revealed that in this case the interaction was Ca2þ-de-
pendent. NMR-unP slightly inhibited the Mg2þ-ATPase activity of actomyosin
reconstructed from molluscan myosin and rabbit F-actin. In contrast, NMR-P
as well as intact phosphorylated myorod increased actomyosin Mg2þ-ATPase
activity of about 1.5-3 fold depending on the experimental conditions.
This finding was supported by a 3-fold higher binding affinity of NMR-P for
myosin filaments with comparison of that of NMR-unP. Taken together these
results implicate that myorod, a thick filament protein of molluscan catch
muscle, can modulate actin-myosin interaction in a phosphorylation-dependent
manner.
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Variation in the structural mechanics of tropomyosin isoforms may govern dif-
ferences in their affinity and positioning on F-actin. Such differences may in-
fluence the access of actin-binding proteins along the sides of actin filaments
and also the cooperativity of actin-myosin interactions. Here, smooth and stri-
ated muscle tropomyosin were rotary shadowed and compared by electron mi-
croscopy. EM shows that cardiac and skeletal tropomyosin primarily consist of
40 nm long single molecules, whereas smooth muscle tropomyosin is a mixture
of varying length chains of end-to-end linked molecules found together with
single molecules. The tendency of smooth muscle tropomyosin to polymerize
reflects greater end-to-end interaction, possibly required on smooth muscle thin
filaments, which lack troponin to stabilize this interaction. Measurement of the
apparent persistence length (PL) of single smooth muscle tropomyosin mole-
cules and the chain-like polymers yield indistinguishable values, which are
comparable to those that we find for cardiac tropomyosin. The semi-rigidity
of smooth muscle tropomyosin polymers may ensure a high degree of posi-
tional fidelity of tropomyosin on smooth muscle thin filaments, despite the
lack of troponin (cf. Lehman et al., 2009). It is unlikely, however, that stiff, po-
lymerized superhelical chains of tropomyosin can bind directly to F-actin.
However, in vitro an equilibrium may yield sufficient single smooth muscle
tropomyosin molecules or short chains to bind. In vivo, actin and smooth mus-
cle (or cytoskeletal) tropomyosin may copolymerize or, alternatively, G-actin
may polymerize on a scaffold of tropomyosin chains. Thus differing mecha-
nisms of thin filaments assembly may be related to tropomyosin end-to-end
binding strength.
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It is commonly believed that the time scale governing the rheology of airway
smooth muscle (ASM) is set by the internal viscosity and elasticity of the mus-
cle. We show here, to the contrary, that this time scale is set by the externally
imposed rate of strain.
For any fixed strain rate amplitude (SRA), the elastic modulus of the ASM
showed a sigmoidal dependence upon frequency. Remarkably, as the SRA
was increased over a range spanning almost four decades, sigmoidal response
curves demonstrated little change of shape but shifted dramatically to higher
frequencies. As such, the time scale of underlying molecular processes is set
not by any internal viscosity, elasticity, or any spontaneous internal rate pro-
cess, but instead is set by the imposed rate of strain. When the muscle is loaded
at a small strain-rate, the molecular dynamics are slow; when loaded at a large
strain-rate, the dynamics are fast.
Using numerical computations, we then assessed the contribution of myosin
bridge kinetics to this behavior. In the regime where frequency was the highest,
a good agreement between data and computations was obtained; ASM dynam-
ics could, therefore, be attributed to forced acto-myosin crossbridge dynamics.
But at the lowest frequencies, the slopes differed dramatically and stiffness
values differed by an order of magnitude, exposing a new domain of slow dy-
namics that cannot be accounted for by acto-myosin interactions.
Interestingly, these results unify scale-free dynamics, fluidization, and length
adaptation. While this unification is not explained by any traditional physical
picture of cell rheology or polymer dynamics, it deepens substantially the anal-
ogy between living and inert soft matter, and in doing so, reveals a central role
for microstructural fragility.2800-Pos
Role of Nonlinear Serial Elasticity on Airway Smooth Muscle Contraction
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Both the elevated shortening velocity and maximal shortening capacity of air-
way smooth muscle (ASM) in asthmatic airways have been associated with air-
way hyperresponsiveness, even though the isometric force-generating capacity
of the muscle is the same as in normal airways. This paradox may be partly ex-
plained by the relaxing role of tidal breathing, which is associated with per-
turbed equilibria of myosin binding. We have developed a theoretical model
of airway narrowing to quantitatively assess how and in what degree the ob-
served alterations in ASM contractility and nonlinear ASM serial elasticity
(SE) can account for hyperresponsiveness in asthma. The model includes the
elasticity and geometry of the lungs, ASM contractility, and the dynamics of
breathing. The airway caliber, proportional to ASM length, is dynamically de-
termined by the balance between the airway wall reaction force (AWRF) and
ASM contractile force. AWRF depends on the instantaneous difference be-
tween pleural pressure and airway pressure at each generation of Weibel’s sym-
metrical bronchial tree, elasticity and geometry of the airway wall, tethering of
the airway to the lung parenchyma, and the state of lung inflation. ASM con-
tractile force depends on myosin binding kinetics and the level of ASM activa-
tion. From equliriated ASM length the airway resistance is calculated. The
model enables simulation of breathing in normal and asthmatic airways ex-
posed to an increasing dose of spasmogen. Increasing the dose causes a contrac-
tion of the ASM, narrowing of the airways, and an exponential increase airway
resistance. We show that an airway with asthmatic or sensitized muscle (in-
creased level of myosin LC20 phosphorylation, by 30-50%) narrows faster
and significantly more than a normal airway. These results lead to a plausible
mechanism by which the rate of bridge cycling and its regulation may account
for airway excessive narrowing in asthma.
2801-Pos
Structural Dynamics of the Dystrophin-Actin and Utrophin-Actin
Complexes
Ava Y. Lin, Ewa Prochniewicz, Davin Henderson, James Ervasti,
David D. Thomas.
University of Minnesota, Minneapolis, MN, USA.
Dystrophin and utrophin bind actin in vitro with similar affinities, but with dif-
ferent molecular contacts. It is proposed that these differences alter the elastic-
ity of dystrophin-actin and utrophin-actin linkages to the sarcolemma, affecting
the cell’s response to muscle stretches. To test this hypothesis, we have deter-
mined the effects of dystrophin and utrophin on the microsecond dynamics of
phosphoresescent-labeled actin, using transient phosphorescence anisotropy
(TPA). At higher levels of saturation, utrophin was more effective than dystro-
phin in causing changes to the final anisotropy, correlation time, and initial
anisotropy of actin dynamics. The simplest interpretation of these changes is
that utrophin restricted the amplitude and increased the rates of actin to a sub-
stantially larger extent than dystrophin. Further analysis indicated that the
actin-utrophin complex is much more torsionally flexible than the actin-dystro-
phin complex. We propose that these differences between dystrophin and
utrophin in their effects on actin dynamics affect elastic properties of actin-me-
diated linkages with the sarcolemma. Preliminary data on fragments containing
all the proposed actin binding domains (DN-R17/UN-R10) show less of an ef-
fect on regulating rotational amplitude and nearly no effect on rotational rate.
Future experiments looking at other fragments of dystrophin and utrophin, and
constructs with engineered disease-causing point mutations will determine
which structural elements of these proteins are critical in determining the
flexibility of actin filaments and what level of actin flexibility is physiologically
optimal. Finally, to test the hypothesis that different orientation or conforma-
tion of the actin binding domain in dystrophin and utrophin contributes to
changes in actin dynamics, we are using spectroscopic probes to do direct dis-
tance measurements between the 2 Calponin homology actin-binding domain
heads to differentiate between the 4 currently proposed models of CH domain
conformations.
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Congenital contracture syndromes affect 1 out of every 1000 live births, and of
those syndromes, distal arthrogryposis (DA), characterized by contractures of
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Sheldon Syndrome (FSS), 97% of the cases are caused by mutations in the em-
bryonic myosin heavy chain gene,MYH3. To assess the effects of this mutation
on adult muscle contractility, skeletal muscle was obtained from a needle bi-
opsy of the gastrocnemius muscle in an FSS individual (MYH3 R672C) and
a control subject were performed and skinned single muscle fibers were
dissected for measurements of contractile performance as the [Ca2þ] of phys-
iological solutions was varied. The magnitude of passive stiffness was 2x
greater for patient fibers. There was no difference in maximal Ca2þ activated
force found in the affected adult muscle fibers (0.204uN 5 0.044) compared
to normal adult muscle fibers (0.259uN 5 0.028). However specific force
was 69% less ; this was attributable to hypertrophy of the patient fibers
(159um 5 8 as compared to normal control myofibers of 87um 5 3). Little
to no change was observed in Ca2þ sensitivity (pCa50) or in cooperativity of
the force-pCa relationship. Relaxation was dramatically slower in patient
fibers, taking 4x longer to reach 50% relaxation and 10x longer to reach 90%
relaxation. Control experiments suggested this is not due to the larger patient
fiber size. Preliminary analysis, using a 12.5% agarose gel, and Western Blots,
indicated that these differences were not fiber type dependent. Interestingly,
we have identified that embryonic myosin (MYH3) is present in single adult
muscle cells. This work was supported by HL65497 (Regnier) and HD48895
(Bamshad).
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Fatigue in a Model of Peripheral Artery Disease in Situ
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CK-1909178 is a member of a class of fast skeletal troponin activators that sen-
sitize skinned skeletal muscle fibers to calcium. In rat muscle preparations in
vitro and in situ, CK-1909178 increased sub-tetanic force without altering max-
imum force. Given that a major cause of muscle fatigue during repeated muscle
contraction is reduced myoplasmic Ca2þ due to impaired sarcoplasmic reticu-
lum Ca2þ release, we tested whether increased calcium sensitivity with CK-
1909178 would slow the development of fatigue. Rat flexor digitorum brevis
muscle was pretreated in vitro with CK-1909178 and stimulated every 3 sec-
onds at a frequency sufficient to achieve 50% of maximum force for 6 min
at 30C. CK-1909178 diminished the extent of fatigue as compared to control
(terminal force 29.558% vs. 12.754%, p<0.001). We next tested whether
CK-1909178 treatment would slow the development of muscle fatigue using
rat extensor digitorum longus muscle in situ, where the muscle was stimulated
via the peroneal nerve. To accelerate the development of muscle fatigue, vas-
cular insufficiency was produced by femoral artery ligation (FAL). Muscle fa-
tigue with FAL and sham ligation in the presence and absence of CK-1909178
was assessed. CK-1909178 was administered as a 5mg/kg intravenous bolus
before assessment of fatigue at a frequency adjusted to achieve the same force
at 30Hz prior to dosing. FAL resulted in significantly reduced terminal tension
as compared to sham (3354% vs. 7755%, p<0.01). CK-1909178 administra-
tion significantly attenuated FAL-induced fatigue at 10 minutes (6157% vs.
3354%, p<0.01). In summary, CK-1909178 increased sub-maximal muscle
force development and reduced the extent of fatigue in the presence of limited
blood flow in situ. We believe that this mechanismmay improve muscle fatigue
in diseases where blood flow to muscles is compromised such as intermittent
claudication.
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The subfragment 2/light meromyosin "hinge" region of myosin II rods forms
a less stable coiled-coil than do flanking regions. Different hinge sequences
may contribute tomuscle specific properties. Transgenic replacement of a portion
of fast muscle myosin hinge A (encoded by exon 15a) in Drosophila indirect
flight muscle (IFM) with slow muscle hinge B (exon 15b) increases rod
coiled-coil propensity, rod and sarcomere lengths and decreases flight perfor-
mance. To characterize the hinges’ nano-mechanical properties we determined
persistence length (PL) differences via electron microscopy and molecular
dynamic (MD) simulations. Rotary shadowed 15b myosin molecules showed
an ~22% higher rod PL relative to 15a (64.2 vs. 50.3 nm) while MD simulationsrevealed an ~39% greater PL for 15b relative to 15a (85 vs. 52 nm). These data
are consistent with a high coiled-coil propensity of exon 15b-containing myosin
rods stiffening the hinge and a substantial portion of the myosin tail. We inves-
tigated myofibrillar ultrastructure by electron microscopy of ultrathin sections of
15b-expressing IFM and observed some sarcomeres with substantially different
Z- to M-line distances on opposing halves of individual sarcomeres. We used
confocal microscopy to quantitatively assess the extent of this asymmetry as
well as the distribution of sarcomeres lengths (SL).We confirmed an ~8% greater
SL, as well as a significant difference between the coefficients of variation in SL,
in hinge B- relative to hinge A-containing myofibrils (3.5550.28 vs. 3.2950.14
mm) (F¼3.39 (p<0.001)).Our data suggest 15b hinge replacement has a stiffen-
ing effect on IFM myosin rods. This may decrease local rod flexibility, promote
molecular packing during filamentous growth and disrupt the regulation of thick
filament lengths, which in turn may account for longer and highly variable SL
and for decreased muscle performance.
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Dystroglycan and the sarcoglycan complex are two essential components of the
dystrophin-glycoprotein complex. Mutations that lead to hypoglycosylation of
dystroglycan result in various limb-girdle and congenital muscular dystrophies
referred to as dystroglycanopathies. Mutations in the genes that encode for sar-
coglycans are associated with limb-girdle muscular dystrophies referred to as
sarcoglycanopathies. Overexpression of the glycosyltransferase LARGE1 in-
duces hyperglycosylation of dystroglycan and bypasses glycosylation defects
present in several distinct dystroglycanopathies. Whether LARGE1 ovexpres-
sion improves contractile properties in dystroglycanopathies and whether the
efficacy of LARGE1 overexpression extends to sarcoglycanopathy has not
been evaluated. We tested the hypothesis that muscle specific LARGE1 over-
expression reduces pathology, increases force production, and protects muscles
of mice deficient in LARGE1 (LARGEmyd mice) or b-sarcoglycan (Sgcb-null
mice) from contraction-induced injury. Mice with LARGE1 overexpression
driven by the muscle creatine kinase promoter were crossed with LARGEmyd
and Sgcb-null mice. Extensor digitorum longus muscles were isolated, specific
forces measured, and force deficits after lengthening contractions were as-
sessed. Functional expression of LARGE1 overexpression and dystroglycan
hyperglycosylation were observed. LARGE1 overexpression in LARGEmyd
mice reduced pathology and improved specific force and force deficit to
wild-type levels. In contrast, overexpression had no beneficial effect for
Sgcb-null mice. The results suggest that the efficacy of muscle specific
LARGE1 overexpression may be limited to dystroglycanopathies.
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Benjamin S. Avner1, Krystyna M. Shioura1, Sarah B. Scruggs2,
D. Lawrence Helseth1, Paul H. Goldspink1, R. John Solaro1.
1University of Illinois at Chicago, Chicago, IL, USA, 2University of
California, Los Angeles, Los Angeles, CA, USA.
Post-translational modifications of the proteins that make up the cardiac sarco-
mere have been suggested as a source of pathological muscle dysfunction. Re-
active oxygen species (ROS) can induce post-translational modifications to
proteins, and an increase in ROS levels is recognized as a feature of heart fail-
ure following myocardial infarction (MI). The experiments described here test
the hypothesis that MI exerts a functional effect through alteration of myofibril-
lar proteins, which can be detected within days after the infarction. Experimen-
tal MI was induced by ligation of the left anterior descending coronary artery in
6-month old female CD1 mice. Samples were collected 3-4 days after ligation
or sham surgery (n¼ 10). We performed functional analysis through force-cal-
cium measurements of detergent-extracted fiber bundles ("skinned fibers") dis-
sected from non-infarcted papillary muscle. Our findings included an increase
in Caþþ sensitivity in fibers from MI hearts compared to those from sham-op-
erated animals and a decreased cooperativity of activation (p < 0.05). Bio-
chemical data derived from electrophoresis of isolated myofibrillar proteins
from these hearts revealed both oxidation and modified phosphorylation. We
used ProQ Diamond phosphoprotein gel stain to analyze myofilament protein
phosphorylation, and nonreducing-reducing "diagonal" SDS-PAGE to detect
the formation of disulfide products. Total troponin I phosphorylation levels
